Memorial Sloan Kettering Cancer Center (MSK) is celebrating the launch of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.
The Future of Cancer Care
“For more than 130 years, MSK has been on the forefront of providing superior clinical care through innovative approaches. The David H. Koch Center for Cancer Care at MSK is the next chapter of this vision,” said Craig B. Thompson, MD, President and CEO of MSK. “This facility expands on MSK’s rich history of innovation in patient care and combines the latest, most intuitive technology with the compassionate, efficient care of our staff. This is the future of cancer care.”
Located on East 74th Street between York Avenue and the FDR Drive, the David H. Koch Center for Cancer Care at MSK sets a new standard in care. Its stewards are 1,300 employees who will work with up to 1,300 patients daily. The outpatient facility occupies 25 floors, with 231 exam rooms, 110 infusion rooms, 37 procedure rooms, and 16 inpatient beds for those requiring a short stay.
The new facility integrates all the lifesaving innovations and clinical advances that MSK has developed in its pioneering effort to care for people with cancer. Nearly every aspect of cancer care across numerous specialties will now be available under one roof, including hematologic oncology, interventional radiology, dermatology, and endocrine, head and neck, pulmonary, and thoracic cancers, as well as phase I clinical trials and more. This will make it possible for patients to receive many of the services they need in a single visit, reducing patient travel and stress while also fostering face-to-face collaboration among care teams and specialists.
“The David H. Koch Center for Cancer Care at MSK creates the space, in every sense of the word, for our breakthrough research and therapies to stand in lockstep with our steadfast commitment to truly care for each person as an individual,” said Lisa DeAngelis, MD, Physician-in-Chief of MSK.
Engaged, Embraced, Empowered
“The vision for the David H. Koch Center for Cancer Care at MSK is to create a caring and healing community where all are engaged, embraced, and empowered,” said Elizabeth McCormick, RN, Chief Nursing Officer of MSK. “That includes the patients we care for, the caregivers at their side, and our researchers, clinicians, and staff who work together in our united mission of conquering cancer.” This is accomplished through a unique approach to state-of-the-art cancer care that encompasses:
A Lasting Legacy
The facility stems from the record donation of $150 million from the late David H. Koch, who served as a long-time member of the MSK Boards of Overseers and Managers. His gift represents the largest single donation in MSK’s history, and his lifelong gifts and pledges to the institution total $230 million. These include funds to establish the David H. Koch Center for the Immunologic Control of Cancer, and three chairs including the David H. Koch Chair.
“My husband saw in this center the potential to transform cancer care around the world, and today his vision becomes reality,” said Julia F. Koch. “David’s legacy of leadership and generosity will persist through this state-of-the-art facility and the lifesaving work of this team.”Back To Top
MSK's $1.5 billion David H. Koch Center for Cancer Care opening in January 2020. Appl Rad Oncol.